Corcept executive reports bona fide stock gifts
Corcept Therapeutics Inc’s Chief Business Officer, Gary Charles Robb, reported several bona fide gift transactions in the company’s common stock on August 12, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corcept Therapeutics Inc’s Chief Business Officer, Gary Charles Robb, reported several bona fide gift transactions in the company’s common stock on August 12, 2026. He made a gift disposition of 11,530 shares, leaving 13,551 shares held directly, including unvested restricted stock awards. He also reported gifts of 3,000 shares to each of two custodial accounts for his children, which are reported as indirect holdings. Separately, an additional 49,716 shares are held indirectly through the Gary Charles Robb TTE Robb Revocable Trust.
Insider Trade Summary
17,530 shares gifted
Gift
4 txns
Insider
Robb Gary Charles
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock F1 | 11,530 | $0.00 | $0.00 |
| Gift | Common Stock F2 | 3,000 | $0.00 | $0.00 |
| Gift | Common Stock F3 | 3,000 | $0.00 | $0.00 |
| holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 13,551 shares (Direct);
Common Stock — 15,571 shares (Indirect, Custodial Account for Child);
Common Stock — 49,716 shares (Indirect, Gary Charles Robb TTE Robb Revocable Trust)
Footnotes (4)
- F1. Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F2. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- F3. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- F4. These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
Key Figures
Direct gift disposition: 11,530 shares of Common Stock
Direct holdings after gift: 13,551 shares of Common Stock
Gifts to custodial accounts: 3,000 shares + 3,000 shares of Common Stock
+3 more
6 metrics
Direct gift disposition
11,530 shares of Common Stock
Bona fide gift on August 12, 2026 from direct holdings
Direct holdings after gift
13,551 shares of Common Stock
Direct ownership following the 11,530-share gift, including unvested RSAs
Gifts to custodial accounts
3,000 shares + 3,000 shares of Common Stock
Bona fide gifts to two child custodial accounts on August 12, 2026
Trust indirect holding
49,716 shares of Common Stock
Held by Gary Charles Robb TTE Robb Revocable Trust, reported as indirect ownership
Unvested restricted stock awards
251, 224, 499, 776 shares
Unvested RSAs granted on Sept 2, 2025; Dec 1, 2025; Mar 2, 2026; Jun 1, 2026
Gift transaction price
$0.0000 per share
Per-share transaction price for reported bona fide gifts
Key Terms
bona fide gift, restricted stock awards, Uniform Transfers to Minors Act, Revocable Trust
4 terms
bona fide gift financial
"transaction_code_description: "Bona fide gift" for multiple stock transfers"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
restricted stock awards financial
"Includes shares underlying unvested restricted stock awards granted to the Reporting Person"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Uniform Transfers to Minors Act financial
"custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian"
Revocable Trust financial
"held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Corcept Therapeutics (CORT) report on August 12, 2026?
Corcept Therapeutics’ Chief Business Officer, Gary Charles Robb, reported three bona fide gift transactions of common stock on August 12, 2026, plus an updated indirect trust holding of 49,716 shares.
What indirect holdings did Gary Charles Robb report in Corcept Therapeutics (CORT) stock?
He reported 3,000 shares held in each of two custodial accounts for his children and an indirect holding of 49,716 shares through the Gary Charles Robb TTE Robb Revocable Trust.
Are the Corcept Therapeutics (CORT) insider transactions sales or gifts?
All reported transactions with a code “G” are described as bona fide gifts of Corcept common stock, not open-market sales or purchases, and are shown at a $0.0000 per-share transaction price.
What unvested restricted stock awards does Gary Charles Robb hold in Corcept Therapeutics (CORT)?
His direct holding of 13,551 shares includes 251, 224, 499, and 776 shares underlying unvested restricted stock awards granted on September 2, 2025; December 1, 2025; March 2, 2026; and June 1, 2026, respectively.
When will Gary Charles Robb’s Corcept (CORT) restricted stock awards vest?
The filing states that 100% of the shares underlying each restricted stock award will vest on the one-year anniversary of the grant date, provided Gary Charles Robb satisfies specified requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
